László Urbán

机构：University of Debrecen, University of Matanzas, National Healthcare Service Center · ORCID：0000-0002-1275-0293

发表论文 422 篇 · 总被引 56174 次 · h-index 73

代表论文

• LBA49 Associations of ctDNA clearance (CL) during neoadjuvant Tx with pathological response and event-free survival (EFS) in pts with resectable NSCLC (R-NSCLC): Expanded analyses from AEGEAN (2024 · Annals of Oncology · 被引 31)
• OA13.03 Perioperative Durvalumab for Resectable NSCLC (R-NSCLC): Updated Outcomes from the Phase 3 AEGEAN Trial (2024 · Journal of Thoracic Oncology · 被引 26)
• Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC (2025 · Journal of Thoracic Oncology · 被引 24)
• Association of post-surgical MRD status with neoadjuvant ctDNA dynamics, genomic mutations, and clinical outcomes in patients with resectable NSCLC (R-NSCLC) from the phase 3 AEGEAN trial. (2025 · Journal of Clinical Oncology · 被引 13)
• HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program (2023 · European Radiology · 被引 12)
• OA14.03 Six-year Survival and HRQoL Outcomes with 1L Nivolumab + Ipilimumab in Patients with Metastatic NSCLC from CheckMate227 (2023 · Journal of Thoracic Oncology · 被引 12)